The Company
The Italian Group for Malignant Myeloproliferative Diseases (AGIMM) is formed by Italian doctors and researchers gathered in a research program focused on chronic “classical” myeloproliferative neoplasms thanks to AIRC (Italian association for cancer research) funding.
The Challenge
Development of a pathology registry for the management and integration of data related to the molecular and clinical studies of chronic myeloproliferative diseases
The solution
Development of a web platform for the management and integration of molecular and clinical data in chronic myeloproliferative diseases. The web platform allows the insertion of personal, diagnostic and follow-up information of each patient, the management of sensitive personal data of patients with appropriate cryptographic techniques, the definition and implementation of appropriate backup policies and the importation of previous data.
Results
– Integration of data from molecular and clinical studies
– Real-time monitoring of patients’ health status
– Optimization of KPI’s search and data analysis through a more intuitive visualization of the data collected in graphical, tabular and on map format